DORZOLAMIDE/TIMOLOL APOTEX 20/5 dorzolamide/timolol eye drops

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

timolol maleate, Quantity: 6.8 mg/mL (Equivalent: timolol, Qty 5 mg); dorzolamide hydrochloride, Quantity: 22.3 mg/mL (Equivalent: dorzolamide, Qty 20 mg)

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Dorzolamide hydrochloride,Timolol maleate

Zāļu forma:

Eye Drops, solution

Kompozīcija:

Excipient Ingredients: mannitol; sodium citrate dihydrate; water for injections; benzalkonium chloride; sodium hydroxide; hyetellose

Ievadīšanas:

Ophthalmic

Vienības iepakojumā:

5 mL

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Dorzolamide/Timolol 20/5 Eye Drops are indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.

Produktu pārskats:

Visual Identification: Clear, colourless to nearly colourless, slightly viscous solution.; Container Type: Bottle; Container Material: LDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2017-01-11